ArticleCureus2025
Concurrent Courses: Exploring the Synchronous Occurrence of Hepatic Myelolipoma and Hepatocellular Carcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelolipomas are benign, nonfunctioning neoplasms that most commonly arise in the adrenal glands and constitute a recognisable subset of adrenal masses. They are primarily composed of haematopoietic cells and fatty tissues. Hepatic myelolipoma is extremely rare, with only 11 cases previously recorded in English medical literature. It is usually an incidental finding. Hepatic myelolipomas are most often identified by ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI), and diagnosis is confirmed with histopathology. In this case report, we describe an exceptionally uncommon case in which a patient presented with aberrant and nonspecific symptoms. He was discovered to have a massive hepatic myelolipoma, as well as elements of hepatocellular carcinoma (HCC). He underwent tumour resection after being carefully reviewed by the sarcoma multidisciplinary team (MDT).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.